Bloomington-based Cook Medical has announced a sales and marketing agreement with Zelegent Inc. in California. Cook says the partnership aims to enhance treatment options for patients suffering from snoring.
As part of the agreement, the two companies will work together to market Zelegent’s Elevo Kit Snoring Intervention Device, a minimally-invasive technology for snoring. The device allows physicians to perform Elevoplasty in an office-based setting with no general anesthesia.
Cook Medical will provide global sales, marketing and distribution support for the device. Cook says the agreement allows the company to expand its product portfolio to include treatment options for snoring.
"We saw a need for new options to help patients struggling with snoring," said Thomas Cherry, OHNS global business leader for Cook Medical. "We found that Zelegent’s solution aligns perfectly with Cook Medical’s mission to support minimally invasive procedures, and we are excited to help bring this technology to patients in the near future."
Zelegent Chief Executive Officer Alexander Arrow says the collaboration with Cook is the next step in bringing Elevoplasty to the offices of sleep disorder specialists and otolaryngologists.